Resolutions approved at the Extraordinary General Meeting of Shareholders Resolutions approved at the Extraordinary General Meeting of Shareholders Amsterdam, December 18, 2025 - STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, announced the results related to the voting items of the Extraordinary General Meeting of Shareholders (EGM) which was held today in Amsterdam. The proposed resolutions were both approved by the Shareholders: the appointment of Armando Varricchio, as member of the Supervisory Board, f...
Approbation des résolutions à l’Assemblée Générale Extraordinaire des Actionnaires Approbation des résolutions à l’Assemblée Générale Extraordinaire des Actionnaires Amsterdam, le 18 décembre 2025 - STMicroelectronics (NYSE: STM), un leader mondial des semiconducteurs dont les clients couvrent toute la gamme des applications électroniques, annonce les résultats relatifs aux résolutions soumises au vote lors de son Assemblée Générale Extraordinaire (AGE) des Actionnaires qui s’est tenue aujourd’hui à Amsterdam (Pays-Bas). Les résolutions proposées ont été approuvées par les actionnaires :...
Two Directors at Getlink SE bought 8,584 shares at between 15.154EUR and 15.180EUR. The significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
A director at Compagnie Financiere Richemont S.A. sold 1,062 shares at 169.772CHF and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
ASML reports transactions under its current share buyback program ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. DateTotal repurchased sharesWeighted average priceTotal repurchased value08-Dec-25 37,576 €962.62 €36,171,308 09-Dec-25 37,838 €955.96 €36,171,562 10-Dec-25 37,860 €955.40 €36,171,421 11-Dec-25 38,288 €944.71 €36,170,938 12-Dec-25 38,329 €943.72 €36,171,668 ASML’s current share buyback program was announced ...
STMicroelectronics et SpaceX célèbrent une décennie de partenariat clé pour la connectivité mondiale de Starlink STMicroelectronics et SpaceX célèbrent une décennie de partenariatclé pour la connectivité mondiale de Starlink Une décennie d'innovation avec des puces sur mesure a donné naissance à une nouvelle industrie offrant une connectivité haut débit aux foyers et entreprises grâce à des satellites évoluant en orbite terrestre basse.Les produits Starlink sont conçus conjointement avec des ingénieurs ST basés en France et en Italie, et fabriqués dans des usines implantées en France, à...
STMicroelectronics and SpaceX celebrate a decade-long partnership key to Starlink global connectivity STMicroelectronics and SpaceX celebrate a decade-long partnershipkey to Starlink global connectivity A decade of innovation with custom-made chips has enabled a new industry with broadband connectivity for homes and businesses using low Earth orbit satellites.Starlink products are co-designed with ST engineers located in France and Italy and manufactured in fabs located in France, Malta and Malaysia. ST’s BiCMOS chip technology is leveraged for Starlink high-performing phased-array antenn...
For access to the full note, please contact Naresh Chouhan ( ) With EU Pharma (ex-Novo) now having reached decade high valuations vs EuroStoxx600, we believe the sector has broken out & the sustainability of the growth profile will now generate continued strong performance. Consensus 5yr sales & EPS CAGR’s stand at 4% & 7% for 15x 2026 PE. We show there is upside to this from underestimated pipelines where cons. rarely fully models “monster” drugs & from M&A which we expect to be strong at JPM ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.